Safety and clinical response of intraventricular caspofungin for Scedosporium apiospermum complex central nervous system infection.

Related Articles

Safety and clinical response of intraventricular caspofungin for Scedosporium apiospermum complex central nervous system infection.

Med Mycol Case Rep. 2016 Sep;13:1-4

Authors: Williams JR, Tenforde MW, Chan JD, Ko A, Graham SM

Abstract
We present a 71-year old woman treated with 14 days of 5 mg intraventricular caspofungin for Scedosporium apiospermum complex meningoencephalitis diagnosed after spinal fusion and instrumentation. Cerebrospinal fluid studies improved during therapy and intraventricular administration was well tolerated. Within weeks of discontinuation, the patient experienced clinical deterioration with disease progression. There are sparse data on the efficacy and safety of administering intraventricular caspofungin. While apparently safe, intraventricular caspofungin was insufficient for disease control in this case.

PMID: 27656356 [PubMed]